Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer

Genetic/Familial High-Risk Assessment: Breast and Ovarian

(2017) Mary B. Daly et al.   Journal of the National Comprehensive Cancer Network

Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer

(2011) A. M. Gonzalez-Angulo et al.   CLINICAL CANCER RESEARCH

Nation-Wide Korean Breast Cancer Data from 2008 Using the Breast Cancer Registration Program

(2011) Yong Sik Jung et al.   Journal of Breast Cancer

Is Screening With Magnetic Resonance Imaging in BRCA Mutation Carriers a Safe and Effective Alternative to Prophylactic Mastectomy?

(2011) Monika L. Burness et al.   JOURNAL OF CLINICAL ONCOLOGY

Should All Women With Breast Cancer Be Tested forBRCAMutations at the Time of Diagnosis?

(2011) Steven A. Narod   JOURNAL OF CLINICAL ONCOLOGY

Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families

(2010) Zsofia K. Stadler et al.   BREAST CANCER RESEARCH AND TREATMENT

Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene

(2010) Ivana Ticha et al.   BREAST CANCER RESEARCH AND TREATMENT

Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families

(2010) Peter Kang et al.   BREAST CANCER RESEARCH AND TREATMENT

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

(2010) Andrew Tutt et al.   LANCET

BRCA mutations in the management of breast cancer: the state of the art

(2010) Steven A. Narod   Nature Reviews Clinical Oncology

Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups

(2009) B. G. Haffty et al.   ANNALS OF ONCOLOGY

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

(2009) SR Young et al.   BMC CANCER

Comprehensive mutational analysis ofBRCA1/BRCA2for Korean breast cancer patients: evidence of a founder mutation

(2009) M-W Seong et al.   CLINICAL GENETICS

BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications

(2009) Allison W Kurian   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Low contribution of BRCA1/2 genomic rearrangement to high-risk breast cancer in the Korean population

(2009) Moon-Woo Seong et al.   Familial Cancer

BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients

(2009) Myong Cheol Lim et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy

(2009) Tomasz Byrski et al.   JOURNAL OF CLINICAL ONCOLOGY

BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer

(2008) Weiqiu Chen et al.   BREAST CANCER RESEARCH AND TREATMENT

Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families

(2008) Thomas v. O. Hansen et al.   BREAST CANCER RESEARCH AND TREATMENT

The Relative Contribution of Point Mutations and Genomic Rearrangements in BRCA1 and BRCA2 in High-Risk Breast Cancer Families

(2008) M. D. Palma et al.   CANCER RESEARCH

Performance ofBRCA1/2Mutation Prediction Models in Asian Americans

(2008) Allison W. Kurian et al.   JOURNAL OF CLINICAL ONCOLOGY